| Introduction to radiomics ME Mayerhoefer, A Materka, G Langs, I Häggström, P Szczypiński, ... Journal of Nuclear Medicine 61 (4), 488-495, 2020 | 904 | 2020 |
| Effects of MRI acquisition parameter variations and protocol heterogeneity on the results of texture analysis and pattern discrimination: an application‐oriented study ME Mayerhoefer, P Szomolanyi, D Jirak, A Materka, S Trattnig Medical physics 36 (4), 1236-1243, 2009 | 229 | 2009 |
| Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study B Snijder, GI Vladimer, N Krall, K Miura, AS Schmolke, C Kornauth, ... The Lancet Haematology 4 (12), e595-e606, 2017 | 169 | 2017 |
| MRI-controlled analysis of 104 patients with painful bone marrow edema in different joint localizations treated with the prostacyclin analogue iloprost. R Meizer, C Radda, G Stolz, S Kotsaris, G Petje, C Krasny, M Wlk, ... Wiener Klinische Wochenschrift 117, 2005 | 152 | 2005 |
| Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel AS Becker, R Perez-Johnston, SA Chikarmane, MM Chen, M El Homsi, ... Radiology 300 (2), E323-E327, 2021 | 151 | 2021 |
| Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions M Eiber, T Takei, M Souvatzoglou, ME Mayerhoefer, S Fürst, FC Gaertner, ... Journal of Nuclear Medicine 55 (2), 191-197, 2014 | 146 | 2014 |
| Detection of degenerative cartilage disease: comparison of high-resolution morphological MR and quantitative T2 mapping at 3.0 Tesla S Apprich, GH Welsch, TC Mamisch, P Szomolanyi, M Mayerhoefer, ... Osteoarthritis and cartilage 18 (9), 1211-1217, 2010 | 143 | 2010 |
| ESMO/ASCO recommendations for a global curriculum in medical oncology edition 2016 C Dittrich, M Kosty, S Jezdic, D Pyle, R Berardi, J Bergh, N El-Saghir, ... ESMO open 1 (5), e000097, 2016 | 133 | 2016 |
| Tumor-associated B-cells induce tumor heterogeneity and therapy resistance R Somasundaram, G Zhang, M Fukunaga-Kalabis, M Perego, C Krepler, ... Nature communications 8 (1), 607, 2017 | 128 | 2017 |
| Shoulder impingement: relationship of clinical symptoms and imaging criteria ME Mayerhoefer, MJ Breitenseher, C Wurnig, A Roposch Clinical Journal of Sport Medicine 19 (2), 83-89, 2009 | 128 | 2009 |
| 23Na MR Imaging at 7 T after Knee Matrix–associated Autologous Chondrocyte Transplantation Preliminary Results S Trattnig, GH Welsch, V Juras, P Szomolanyi, ME Mayerhoefer, ... Radiology 257 (1), 175-184, 2010 | 127 | 2010 |
| Skeletal muscle depletion and markers for cancer cachexia are strong prognostic factors in epithelial ovarian cancer S Aust, T Knogler, D Pils, E Obermayr, A Reinthaller, L Zahn, I Radlgruber, ... PloS one 10 (10), e0140403, 2015 | 126 | 2015 |
| Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients ME Mayerhoefer, G Karanikas, K Kletter, H Prosch, B Kiesewetter, ... Clinical Cancer Research 20 (11), 2984-2993, 2014 | 117 | 2014 |
| Texture‐based classification of focal liver lesions on MRI at 3.0 Tesla: A feasibility study in cysts and hemangiomas ME Mayerhoefer, W Schima, S Trattnig, K Pinker, V Berger‐Kulemann, ... Journal of Magnetic Resonance Imaging 32 (2), 352-359, 2010 | 116 | 2010 |
| PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations ME Mayerhoefer, H Prosch, L Beer, D Tamandl, T Beyer, C Hoeller, ... European journal of nuclear medicine and molecular imaging 47, 51-60, 2020 | 110 | 2020 |
| Texture-based classification of different gastric tumors at contrast-enhanced CT A Ba-Ssalamah, D Muin, R Schernthaner, C Kulinna-Cosentini, N Bastati, ... European journal of radiology 82 (10), e537-e543, 2013 | 110 | 2013 |
| Texture‐based and diffusion‐weighted discrimination of parotid gland lesions on MR images at 3.0 Tesla J Fruehwald‐Pallamar, C Czerny, L Holzer‐Fruehwald, SF Nemec, ... NMR in biomedicine 26 (11), 1372-1379, 2013 | 109 | 2013 |
| Integrated contrast-enhanced diagnostic whole-body PET/CT as a first-line restaging modality in patients with suspected metastatic recurrence of breast cancer A Dirisamer, BS Halpern, D Flöry, F Wolf, M Beheshti, ME Mayerhoefer, ... European journal of radiology 73 (2), 294-299, 2010 | 107 | 2010 |
| Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia PB Staber, M Herling, M Bellido, ED Jacobsen, MS Davids, TM Kadia, ... Blood, The Journal of the American Society of Hematology 134 (14), 1132-1143, 2019 | 97 | 2019 |
| Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders C Kornauth, T Pemovska, GI Vladimer, G Bayer, M Bergmann, S Eder, ... Cancer discovery 12 (2), 372-387, 2022 | 87 | 2022 |
